In the quest for longevity and health, early cancer detection is emerging as a critical health indication. Over recent years, an innovative and highly anticipated technology - Circulating Tumor Cell (CTC) detection, has been at the forefront of the revolution in early cancer detection. In comparison to conventional screening methods, CTC technology demonstrates distinct and pioneering advantages in the diagnosis of early-stage cancer, becoming an indispensable component of comprehensive healthcare management. Why should CTC detection be performed when clinical doctors generally recommend using traditional imaging as a diagnostic method for cancer? In the past, traditional imaging always played a vital role in cancer diagnosis. However, CanTell CTC test has opened up a different pathway, providing clinicians with valuable early cancer detection tools and the public with a new concept of health risk management. In the ultra-early stage of cancer, traditional imaging methods often limited by the size of the tumor, making it difficult to capture its presence.. As a result, most patients are diagnosed relatively late. CTC technology focus on detecting circulating tumor cells in the bloodstream, which can extract 1-100 intact CTCs from billions of cells in blood. Even in the blood of healthy individuals, CTCs are relatively rare, making the detection challenging. CanTell CTC testing technology has been maturely developed and successfully overcomes the technical difficulties in the past. By utilizing cutting-edge technology, it precisely screens out CTCs in the blood, achieving the detection of cancer cell risk at a very early stage Comparison of CanTell CTC testing and traditional imaging CanTell CTC detection goes beyond early cancer detection; it serves as an early risk alert, predicts recurrence, and evaluates treatment effectiveness, providing a comprehensive understanding of cancer development. Compared to traditional imaging methods, CanTell CTC test does not require exposure to radiation, and only a simple blood draw is required to perform the test in the ultra-early stage of cancer development and assess risk. The significance of CanTell CTC test for both healthy population and cancer patients For the healthy population, when the CanTell CTC test result is equal to or greater than 4, it indicates a medium risk. This suggests the presence of a small number of tumor cells in the blood circulation system, slightly increasing the risk of developing cancer compared to the general population. If the CTC number exceeds 10, the risk is considered medium to high. It is recommended to arrange further physical examinations, consult with a doctor for professional advice and develop a suitable health management plan. If the CanTell CTC test result is less than 4, it indicates the absence or a minimal number of tumor cells in the blood circulation system, resulting in a lower risk of developing cancer. Regular observation and monitoring are recommended. . For cancer patients, the variation in CTC number is related to the malignancy of the tumor, the risk of metastasis and recurrence, and the prognosis. Sustained in high levels or increasing CTC numbers may reflect poor treatment effectiveness, or indicate a higher risk of tumor recurrence, metastasis, or progression. If the CTC number is less than 4, it reflects good treatment effectiveness or stable condition but there is still a small possibility of disease progression. Close monitoring is recommended in such cases. In the fast-paced modern social life, we have to pay extral attention to our health, especially for fatal diseases like cancer. Through cutting-edge early cancer detection, we could detect the potential risk of cancer early and take appropriate measures to safeguard our future well-being. The CanTell CTC test technology has provided a more efficient and precise solution for early cancer detection. Let us prioritize our health, stay far away from the threat of cancer, and embrace a life that is abundant and extraordinary. CanTell CTC technology is a promising new technology for early cancer detection. It has the advantages of being harmless, simple to use, and able to detect cancer in the ultra-early stage. It is a valuable tool for clinicians and the public in the fight against cancer.
